Advertisement

Ménière Disease

  • Iee-Ching Wu Anderson
  • John P. Carey
  • Walter Kutz
  • William H. SlatteryIII

Abstract

A computerized PubMed search of MEDLINE 1966-May 2005 was performed. The terms “Meniere disease” and “gentamicin” were exploded, and the resulting articles were combined. The terms “intratympanic” and “transtympanic” were entered as text words as the search term “intratympanic OR transtympanic,” and the results were combined with the Ménière disease/gentamicin articles. The resulting 136 articles were limited to the English language, leading to the selection of 115 articles that were reviewed in detail. These articles were reviewed to identify those that met the following inclusion criteria: 1) distinct patient populations defined as those adults with definite Ménière disease, as defined by the 1985 [1] or 1995 [2] guidelines of the Committee on Hearing and Equilibrium of the American Academy of Otolaryngology—Head and Neck Surgery (AAO-HNS), who had failed medical management, 2) intervention with unilateral intratympanic gentamicin therapy, and 3) outcome measures consisting of quantitative or semiquantitative evaluation of vestibular complaints.

Keywords

Hearing Loss Prospective Control Trial Pure Tone Average Vertigo Attack Speech Discrimination Score 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pearson BW, Brackmann DE. Committee on Hearing and Equilibrium guidelines for reporting treatment results in Ménière’s disease. Otolaryngol Head Neck Surg 1985;93(5): 579–581.PubMedGoogle Scholar
  2. 3.
    Stokroos R, Kingma H. Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Ménière’s disease: a prospective, double-blind, placebo-controlled, randomized clinical trial. Acta Otolaryngol 2004; 124(2):172–175.CrossRefPubMedGoogle Scholar
  3. 4.
    Quaranta A, Scaringi A, Aloidi A, Quaranta N, Salonna I. Intratympanic therapy for Ménière’s disease: effect of administration of low concentration of gentamicin. Acta Otolaryngol 2001;121(3):387–392.CrossRefPubMedGoogle Scholar
  4. 5.
    Cohen-Kerem R, Kisilevsky V, Einarson TR, Kozer E, Koren G, Rutka JA. Intratympanic gentamicin for Ménière’s disease: a meta-analysis. Laryngoscope 2004;114(12):2085–2091.CrossRefPubMedGoogle Scholar
  5. 6.
    Chia SH, Gamst AC, Anderson JP, Harris JP. Intratympanic gentamicin therapy for Ménière’s disease: a meta-analysis. Otol Neurotol 2004;25(4):544–552.CrossRefPubMedGoogle Scholar
  6. 7.
    Bentsianov BL, Boruk M, Rosenfeld RM. Evidence-based medicine in otolaryngology journals. Otolaryngol Head Neck Surg 2002;126(4):371–376.CrossRefPubMedGoogle Scholar
  7. 8.
    Silverstein H, Smouha E, Jones R. Natural history vs. surgery for Meniere’s disease. Otolaryngol Head Neck Surg 1989; 100(1):6–16.PubMedGoogle Scholar

References

  1. 1.
    Pearson BW, Brackmann DE. Committee on Hearing and Equilibrium guidelines for reporting treatment results in Ménière’s disease. Otolaryngol Head Neck Surg 1985;93(5): 579–581.PubMedGoogle Scholar
  2. 2.
    Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière’s disease, American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113(3): 181–185.CrossRefGoogle Scholar
  3. 3.
    Quaranta A, Scaringi A, Aloidi A, Quaranta N, Salonna I. Intratympanic therapy for Ménière’s disease: effect of administration of low concentration of gentamicin. Acta Otolaryngol 2001;121(3):387–392.CrossRefPubMedGoogle Scholar
  4. 4.
    Cohen-Kerem R, Kisilevsky V, Einarson TR, et al. Intratympanic gentamicin for Ménière’s disease: a meta-analysis. Laryngoscope 2004;114(12):2085–2091.CrossRefPubMedGoogle Scholar
  5. 5.
    Chia SH, Gamst AC, Anderson JP, Harris JP. Intratympanic gentamicin therapy for Ménière’s disease: a meta-analysis. Otol Neurotol 2004;25(4):544–552.CrossRefPubMedGoogle Scholar
  6. 6.
    Bentsianov BL, Boruk M, Rosenfeld RM. Evidence-based medicine in otolaryngology journals. Otolaryngol Head Neck Surg 2002;126(4):371–376.CrossRefPubMedGoogle Scholar
  7. 7.
    Santos PM, Hall RA, Snyder JM, Hughes LF, Dobie RA. Diuretic and diet effect on Meniere’s disease evaluated by the 1985 Committee on Hearing and Equilibrium guidelines. Otolaryngol Head Neck Surg 1993;109(4):680–689.PubMedGoogle Scholar

References

  1. 1.
    Thomsen J, Bonding P, Becker B, Stage J, Tos M. The non-specific effect of endolymphatic sac surgery in treatment of Ménière’s disease: a prospective, randomized controlled study comparing “classic” endolymphatic sac surgery with the insertion of a ventilating tube in the tympanic membrane. Acta Otolaryngol 1998;118(6):769–773.CrossRefPubMedGoogle Scholar
  2. 2.
    Thomsen J, Bretlau P, Tos M, Johnsen NJ. Placebo effect in surgery for Ménière’s disease. A double-blind placebo-controlled study on endolymphatic sac shunt surgery. Arch Otolaryngol 1981;107(5):271–277.PubMedGoogle Scholar
  3. 3.
    Silverstein H, Smouha E, Jones R. Natural history vs. surgery for Ménière’s disease. Otolaryngol Head Neck Surg 1989;100(1):6–16.PubMedGoogle Scholar
  4. 4.
    Quaranta A, Marini F, Sallustio V. Long-term outcome of Ménière’s disease: endolymphatic mastoid shunt versus natural history. Audiol Neurootol 1998;3(1):54–60.CrossRefPubMedGoogle Scholar

References

  1. 1.
    Thomsen J, Bonding P, Becker B, Stage J, Tos M. The nonspecific effect of endolymphatic sac surgery in treatment of Ménière’s disease: a prospective, randomized controlled study comparing “classic” endolymphatic sac surgery with the insertion of a ventilating tube in the tympanic membrane. Acta Otolaryngol 1998;118(6):769–773.CrossRefPubMedGoogle Scholar
  2. 2.
    Thomsen J, Bretlau P, Tos M, Johnsen NJ. Placebo effect in surgery for Ménière’s disease. A double-blind, placebo-controlled study on endolymphatic sac shunt surgery. Arch Otolaryngol 1981;107(5):271–277.PubMedGoogle Scholar
  3. 3.
    Quaranta A, Onofri M, Sallustio V, Iurato S. Comparison of long-term hearing results after vestibular neurectomy, endolymphatic mastoid shunt, and medical therapy. Am J Otol 1997;18(4):444–448.PubMedGoogle Scholar
  4. 4.
    Goin DW, Mischke RE, Esses BA, Young D, Priest EA, Whitmoyer-Goin V. Hearing results from endolymphatic sac surgery. Am J Otol 1992;13(5):393–397.PubMedGoogle Scholar

References

  1. 1.
    Gacek RR, Gacek MR. Comparison of labyrinthectomy and vestibular neurectomy in the control of vertigo. Laryngoscope 1996;106(2 Pt 1):225–230.CrossRefPubMedGoogle Scholar
  2. 2.
    Kaylie DM, Jackson CG, Gardner EK. Surgical management of Ménière’s disease in the era of gentamicin. Otolaryngol Head Neck Surg 2005;132(3):443–450.CrossRefPubMedGoogle Scholar
  3. 3.
    Glasscock ME 3rd, Hughes GB, Davis WE, Jackson CG. Labyrinthectomy versus middle fossa vestibular nerve section in Ménière’s disease. A critical evaluation of relief of vertigo. Ann Otol Rhinol Laryngol 1980;89(4 Pt 1):318–324.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Iee-Ching Wu Anderson
    • 1
  • John P. Carey
    • 1
  • Walter Kutz
    • 2
  • William H. SlatteryIII
    • 3
  1. 1.Otolaryngology-Head & Neck SurgeryThe Johns Hopkins University School of MedicineBaltimoreUSA
  2. 2.House Ear ClinicLos AngelesUSA
  3. 3.University of Southern CaliforniaLos AngelesUSA

Personalised recommendations